Medelis Europe

Medelis Europe delivers complete oncology drug development services from preclinical through marketing approval in Europe and in Russia.

European, U.S. and Asian sponsors who wish to receive marketing approval in the U.S. and European markets can now take advantage of Medelis’ full service offering.  The key differences in running a successful study in Europe over the U.S. involve knowledge of the local regulatory processes and having experience in feasibility studies to determine the right countries and investigators.  Taking advantage of the costs differences in Eastern Europe can be very attractive to some clients.

Medelis Europe is led by Dr. Ron van Eijsden. His experience in the different country regulatory schemes and deep knowledge of key investigator and site groups, as well as patient advocacy organizations, makes him a valuable asset to Medelis clients.

Explore our services in more detail, or review our recent experience.